Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer.

Bullrich F, MacLachlan TK, Sang N, Druck T, Veronese ML, Allen SL, Chiorazzi N, Koff A, Heubner K, Croce CM, et al.

Cancer Res. 1995 Mar 15;55(6):1199-205.

2.

Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.

Schulze-Gahmen U, Jung JU, Kim SH.

Structure. 1999 Mar 15;7(3):245-54.

3.

[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].

Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.

Cancer Radiother. 2001 Apr;5(2):109-29. Review. French.

PMID:
11355576
4.

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.

Blood. 2000 Oct 15;96(8):2746-54.

6.
7.

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Reynisdóttir I, Polyak K, Iavarone A, Massagué J.

Genes Dev. 1995 Aug 1;9(15):1831-45.

8.
9.
10.

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.

Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ.

Genes Dev. 1995 Mar 15;9(6):650-62.

11.
12.

The cell cycle kinases.

Pines J.

Semin Cancer Biol. 1994 Aug;5(4):305-13. Review.

PMID:
7803767
13.

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Toyoshima H, Hunter T.

Cell. 1994 Jul 15;78(1):67-74.

PMID:
8033213
14.

Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.

Van Dross R, Yao S, Asad S, Westlake G, Mays DJ, Barquero L, Duell S, Pietenpol JA, Browning PJ.

J Natl Cancer Inst. 2005 May 4;97(9):656-66.

PMID:
15870436
15.

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.

Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ.

Mol Cell Biol. 1995 May;15(5):2672-81.

16.

High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.

Bourcigaux N, Gaston V, Logié A, Bertagna X, Le Bouc Y, Gicquel C.

J Clin Endocrinol Metab. 2000 Jan;85(1):322-30.

PMID:
10634406
17.

Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.

Li Y, Jenkins CW, Nichols MA, Xiong Y.

Oncogene. 1994 Aug;9(8):2261-8.

PMID:
7913544
18.
19.

Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.

Braun K, Hölzl G, Soucek T, Geisen C, Möröy T, Hengstschläger M.

Oncogene. 1998 Oct 29;17(17):2259-69.

20.

Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes.

Firpo EJ, Koff A, Solomon MJ, Roberts JM.

Mol Cell Biol. 1994 Jul;14(7):4889-901.

Supplemental Content

Support Center